NextGen Healthcare EBIT

The latest EBIT for NXGN is $12M as of September 2023. That compares with $25M in the prior-year period — down 52.3% year over year. That is below the Technology sector average of $13T. Investors often review this figure alongside NextGen Healthcare's historical trend and sector peers before judging valuation or financial health.

Over the past year, NXGN's EBIT moved from $25M to $12M — a 52.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NextGen Healthcare's operating scale or balance-sheet position.

Against Technology companies, NXGN currently prints $12M for EBIT, while the sector average sits near $13T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at NextGen Healthcare's growth, margins, and balance sheet.

A EBIT figure of $12M for NXGN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $13T. Explore the charts below for those layers of context.

After noting NXGN's EBIT ($12M), review year-over-year change from $25M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.